Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ketorolac
Drug ID BADD_D01232
Description Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.[L6358][L6508][L11055][L3674][L11070] It's analgesic properties make it a useful pain management tool across many settings including postoperative pain, rheumatoid arthritis, osteoarthritis, menstrual disorders, headaches, spinal and soft tissue pain, and ankylosing spondylitis.[L6520] Impressively, ketorolac has a similar efficacy to standard doses of morphine and meperidine making it a useful opioid sparing agent.[L6511]
Indications and Usage Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and has antipyretic, analgesic and anti-inflammatory properties.[A176131] It is indicated for short term management of acute pain that requires the calibre of pain management offered by opioids.[L3674] Clinicians may choose to initiate ketorolac to manage post-operative pain, spinal and soft tissue pain, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, menstrual disorders and headaches among other ailments.[L6520] Regardless of the etiology of pain, patients should use the lowest possible dose, and avoid using ketorolac for an extended period of time (ideally ≤ 5 days).[L3674] A benefit of choosing ketorolac over other analgesics with similar potency is that that there does not appear to be a risk of dependence or tolerance with ketorolac use.[A176131]
Marketing Status approved
ATC Code M01AB15; S01BC05
DrugBank ID DB00465
KEGG ID D08104
MeSH ID D020910
PubChem ID 3826
TTD Drug ID D0D9JW
NDC Product Code Not Available
UNII YZI5105V0L
Synonyms Ketorolac
Chemical Information
Molecular Formula C15H13NO3
CAS Registry Number 74103-06-3
SMILES C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Infertility female21.03.02.017--Not Available
Inflammatory bowel disease07.08.01.016--Not Available
Injection site pain12.07.03.011; 08.02.03.0100.000427%Not Available
Injection site rash23.03.13.010; 12.07.03.032; 08.02.03.032--Not Available
Injection site vesicles23.03.01.024; 12.07.03.051; 08.02.03.051--Not Available
Insomnia19.02.01.002; 17.15.03.002--
Intestinal obstruction07.13.01.002--Not Available
Intraocular pressure increased13.07.04.002--Not Available
Iritis10.02.01.022; 06.04.03.002--Not Available
Jaundice09.01.01.004; 23.03.03.030; 01.06.04.004--Not Available
Jaundice cholestatic09.01.01.005--Not Available
Keratitis06.04.02.002--
Lacrimation increased06.08.02.0040.000262%
Laryngeal oedema23.04.01.005; 22.04.02.001; 10.01.05.003--
Leukopenia01.02.02.001--Not Available
Loss of consciousness17.02.04.0040.000097%Not Available
Lymphadenopathy01.09.01.002--Not Available
Malaise08.01.01.0030.000708%
Melaena24.07.02.013; 07.12.02.004--Not Available
Meningitis aseptic17.06.03.002; 11.01.03.002--Not Available
Mental disability26.01.01.001--Not Available
Mental impairment19.21.02.003; 17.03.03.002--Not Available
Mouth ulceration07.05.06.004--Not Available
Muscle spasms15.05.03.004--
Myalgia15.05.02.001--
Myocardial infarction24.04.04.009; 02.02.02.007--
Nasal congestion22.04.04.001--
Nausea07.01.07.0010.002125%
Neck pain15.03.04.009--
Nephritis20.05.02.001--Not Available
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 9 Pages